INTRODUCTION
============

The term vitamin B6 refers to a group of six water soluble vitamers (**Figure [1](#F1){ref-type="fig"}**), namely pyridoxal (PL), pyridoxine (PN), pyridoxamine (PM), and their phosphorylated derivatives. Pyridoxal-5^′^-phosphate (PLP) is the vitamer of central importance because it is required as a cofactor for over 140 chemical reactions in the cell ([@B21]). In particular, it is involved in amino acid, sugar, and fatty acid metabolism ([@B43]). Only plants, fungi, and bacteria can biosynthesize vitamin B6 *de novo*, therefore animals and humans must obtain it from their diet. Various factors such as inadequate food intake, limited dietary diversity, or diseases can cause vitamin B6 deficiency ([@B10]). Based on the ability of plants to biosynthesize and accumulate vitamin B6 ([@B6]; [@B46]), increasing levels of the vitamin in crops can be a direct way to provide enriched food to the population and reduce the corresponding deficiencies ([@B32]; [@B14]; [@B3]). During the last decade, the function and regulation of key genes involved in vitamin B6 biosynthesis have been characterized in the model plant *Arabidopsis*, revealing the importance of the vitamin in plant development, photosynthesis and responses to stress (reviewed in [@B36]). Therefore, the current molecular understanding of vitamin B6 metabolism provides the opportunity of developing crop plants with an increased content of this vitamin beneficial for both human health and improved agronomic performance.

![**Plants as a source of vitamin B6 and its uptake by humans**. Plants can biosynthesize vitamin B6 *de novo.*It is predominantly produced in the metabolically active parts of the plant like the leaves but can be found in all organs. The*de novo*pathway (upper left corner) is operating in the cytosol involving only two enzymes: a synthase, PDX1, and a glutaminase, PDX2. The abbreviations used are Glu (glutamate), Gln (glutamine), G3P (glyceraldehyde 3-phosphate), R5P (ribose 5-phosphate), PA (pyridoxic acid), PN (pyridoxine), PN-Glu (PN-glycoside), PL (pyridoxal), PM (pyridoxamine), PNP (pyridoxine 5^′^-phosphate), PLP (pyridoxal 5^′^-phosphate), PMP (pyridoxamine 5^′^-phosphate). The cofactor form of the vitamin, PLP, is produced directly from R5P, G3P, and Gln. A salvage pathway also operates in plants (upper right corner) through which the vitamers can be interconverted. PDX3 is a PNP/PMP oxidase (only the reaction for PNP is depicted), SOS4 is a PN/PL/PM kinase and PLR is a PL reductase. Plants can also convert PN to PN-Glu, a form that is only partially bioavailable to humans, using a glycosyl transferase. In the human body, vitamin B6 is taken up in the jejunum (the second part of the small intestine; lower panel) where the free forms PN, PL, and PM can be taken up directly. The phosphorylated vitamers are dephosphorylated prior to uptake by a membrane bound alkaline phosphatase. In both cases uptake is driven by diffusion, which necessitates the phosphorylation of the vitamers immediately after their internalization to keep a low concentration of the non-phosphorylated forms inside the cells. The PN-Glu is taken up in its glycosylated form and processed by a cytosolic β-glucosidase to release PN. Its low bioavailability is not determined by the uptake itself but by the limiting activity of a β-glucosidase. The uptake is followed by further conversion inside the cells (salvage pathway) yielding the active cofactor form PLP involved in numerous biochemical and physiological processes in the human body (right lower panel). The catabolism of the vitamin involves conversion to PA (as well as more oxidized derivatives as depicted). The latter are excreted in the urine.](fpls-04-00143-g001){#F1}

VITAMIN B6: BENEFITS FOR HUMANS
===============================

A vitamin is defined as an organic compound required in limited amounts by an organism that cannot produce it and thus needs to take it up with the diet. The importance of vitamin B6 for human health has been widely reported. Studies have shown that vitamin B6 intake reduces the incidence of important human diseases such as cardiovascular disease, hypertension, epilepsy, diabetes, kidney disease, neurological disorders, and pellagra ([@B21]; **Figure [1](#F1){ref-type="fig"}**). Furthermore, the cofactor form of vitamin B6 (PLP) may have positive effects on various forms of cancer by strengthening the immune system and delaying tumor progression ([@B15]). Other studies investigating the impact of vitamin B6 deficiency on health, using the concentration of PLP in the blood as a biomarker, suggest that a low plasma level correlates with multifactorial neurological pathologies such as depression, Alzheimer's disease, autism, schizophrenia, epilepsy, and Parkinson's disease ([@B10]). On the other hand, the beneficial impact of the vitamin on human health is illustrated by reduced mortality and improved health of the elderly with an adequate PLP plasma concentration ([@B38]; [@B25]). More recently, vitamin B6 deficiency was suggested as the cause of "nodding syndrome," a disease affecting a growing number of children in Uganda and Southern Sudan ([@B61]; [@B60]). Importantly, vitamin B6 is also a potent antioxidant ([@B12]; [@B41]; [@B4]). Several studies focusing on the effect of PN on cell cultures indicate that vitamin B6 functions as a protectant against reactive oxygen species produced in the human body ([@B26]; [@B27]; [@B30]). Among other factors, malnutrition, pregnancy, diabetes, HIV, alcoholism, and the use of oral contraceptives increase the risk of vitamin B6 deficiency ([@B34]; [@B10]; [@B14]). Limited dietary diversity can accentuate micronutrient deficiencies ([@B1]) and is the major cause of a vitamin B6 deficit for inhabitants of developing countries. However, inadequate vitamin B6 status has recently been reported in the U.S.A. as well ([@B37]).

MAIN SOURCES
============

Vitamin B6 is present in many food products including meat and vegetables. The major sources of vitamin B6 in Western diets are cereals, poultry, beef, and potatoes ([@B40]). Among the five most important staple crops, potatoes have by far the highest vitamin B6 content ([@B14]). The content is much lower in other staple crops and should be increased several fold (e.g., wheat 12.2-, rice 3.2-, maize 3.5-, and cassava 2.3-fold, respectively) in order to reach the recommended daily allowance (RDA) of vitamin B6 ([@B14]). The bioavailability of vitamin B6 derived from plant food sources is also an important factor influencing adequate intake (**Figure [1](#F1){ref-type="fig"}**). Plants contain multiple B6 vitamers and a substantial fraction of vitamin B6 is present as pyridoxine-5^′^-β-[D]{.smallcaps}-glucoside (PN-glucoside; [@B18]; [@B39]; **Figure [1](#F1){ref-type="fig"}**). While PN, PL, and PM and their phosphorylated derivatives are fully bioavailable from plant food, PN-glucoside is only 50% bioavailable ([@B17]; **Figure [1](#F1){ref-type="fig"}**). On the other hand, PN and its glycosylated form are more stable than PL and PLP (the main forms of the vitamin available in animal tissues; [@B33]) and are less susceptible to thermal degradation.

VITAMIN B6: BENEFITS FOR PLANTS
===============================

Unlike animals, plants can biosynthesize their own vitamins with the exception of vitamin B12. In the plant context, therefore, the term vitamin does not correspond to its definition but has been widely used. In plants, as in animals, vitamin B6 is required as a cofactor. There are an estimated 177 PLP-dependent enzymes in *Arabidopsis*([@B44]; [@B36]). These enzymes have a central role because they participate in universal (e.g., biosynthesis and catabolism of amino acids) as well as plant specific pathways (e.g., starch metabolism, glucosinolate biosynthesis, ethylene and auxin biosynthesis and degradation; [@B36]). To date, the importance of the B6 vitamers *in planta*has mostly been demonstrated from the analysis of mutant plants deficient in vitamin B6 biosynthesis. For example, an *Arabidopsis* mutant, *rsr4-1*, with reduced *de novo* biosynthesis displays altered levels of metabolites such as amino acids and organic acids ([@B62]). Moreover, *Arabidopsis*mutants that accumulate lower vitamin B6 levels, i.e., *rsr4-1, pdx1.1, pdx1.3*, are phenotypically distinct from wild-type plants because of impaired seed and seedling development, delayed flowering and reduced plant growth ([@B5]; [@B57], [@B56]; [@B59]; [@B62]). Complete biosynthesis knockout mutants (i.e., *pdx2, pdx1.1, pdx1.3*) are embryo lethal ([@B57]; [@B59]). The increased sensitivity of the mutants with reduced levels of vitamin B6 to high concentrations of sucrose, salt, and mannose, as well as high light, UV-B and oxidative stress ([@B5]; [@B59]; [@B20]; [@B48]) indicates that vitamin B6 has an important function in plant stress responses as well. Indeed, *Arabidopsis* plants accumulate vitamin B6 when exposed to UV-B ([@B48]) and increased levels of the vitamin in transgenic *Arabidopsis* confer tolerance to oxidative stress ([@B46]). The potent *in vitro* antioxidant activities of some B6 vitamers also corroborate this particular function of the vitamin ([@B12]; [@B4]; [@B9]). In addition, metabolite profiling has revealed increased lipid peroxidation in the *Arabidopsis rsr4-1* mutant deficient in vitamin B6 biosynthesis *de novo*([@B29]), consistent with its role as an antioxidant. Furthermore, the hypersensitive response triggered in tobacco upon incompatible bacterial infection is delayed following leaf infiltration with PN ([@B9]). Supplementation of *Arabidopsis*growth medium with the same vitamer reduces singlet oxygen-mediated cell death in the conditional *flu* mutant ([@B7]). Notably, the phenotype of the latter mutant was also shown to be attenuated in plants with enhanced levels of vitamin B6 ([@B46]). Similarly, PN supplementation was demonstrated to restore accumulation of the D1 protein in the *pdx1.3* mutant of *Arabidopsis*([@B59]). As the degradation of this protein is known to be triggered by singlet oxygen generated in the reaction center of photosystem II, its steady state level reflects the oxidative state of the chloroplast. Application of exogenous vitamin B6 on leaf disks also reduces singlet oxygen accumulation caused by high light exposure in wild-type and *pdx1.3* mutant plants ([@B20]).

Although vitamin B6 in plants is biosynthesized *de novo* (**Figure [1](#F1){ref-type="fig"}**), the supplementation experiments discussed above and a similar study using PL, PM, and PN ([@B24]) suggest that plants can take up exogenously supplied non-phosphorylated B6 vitamers. This is corroborated by the rescue of the root and leaf developmental phenotypes associated with the *Arabidopsis pdx1.1* and *pdx1.3* mutants ([@B59]; [@B62]) and rescue of the arrest of embryo development at the globular stage in the *pdx2* mutant of *Arabidopsis* by direct application of PN ([@B56]). The latter study indicates that some transfer of the vitamin occurs between the embryo and the maternal tissue. Very recently a purine permease (PUP1) has been shown to function in recycling of vitamin B6 during guttation ([@B55]) but no other transporters for this vitamin have been described so far in plants. Since *de novo* vitamin B6 biosynthesis occurs in the cytosol ([@B57]), diffusion or active transport of vitamin B6 across organelle envelopes is required to support the activity of organellar enzymes dependent on the vitamin as a cofactor ([@B16]). The relatively high polarity of the phosphorylated derivatives of the vitamin does not favor a passive diffusion mechanism ([@B36]) and would require the existence of transporters.

GENETIC ENGINEERING STRATEGIES TO INCREASE VITAMIN B6 IN CROPS
==============================================================

From a genetic engineering perspective, it is attractive that *de novo* vitamin B6 biosynthesis in plants involves only two enzymes, PDX1 and PDX2 ([@B12]; [@B11]; [@B57]; **Figure [1](#F1){ref-type="fig"}**). This pathway is also referred to as deoxyxylulose 5-phosphate (DXP)-independent ([@B57]) to distinguish it from the seven enzyme DXP-dependent pathway first unraveled in *E. coli*(reviewed in [@B13]) and only found in a small subset of bacteria ([@B12]; [@B35]). Interestingly, *Arabidopsis* has three PDX1 homologs, only two of which catalyze vitamin B6 biosynthesis PDX1.1 and PDX1.3 with the function of the third homolog PDX1.2 remaining to be unraveled, and only one PDX2 homolog ([@B57]). Analyses of the rice and cassava genomes ([@B42]; [@B45]) have revealed an identical number of homologs for both genes.

Efforts to increase vitamin B6 accumulation in plants have so far been focused on genes from the DXP-independent pathway. In a first attempt, the *PDX1* and *PDX2* genes from *Cercospora nicotianae*were heterologously expressed in tobacco resulting in a 1.2-fold increase in total vitamin B6 content (**Figure [2](#F2){ref-type="fig"}**), with some of the transgenic lines displaying delayed seed germination and plant growth ([@B22]). Moreover, the expression of the endogenous *PDX* genes was altered in these lines, and a tight regulation of vitamin B6 homeostasis in plants was suggested. In another approach, *PDX1.3* and/or *PDX2*were expressed in *Arabidopsis*under the control of the constitutive 35S cauliflower mosaic virus (CaMV) promoter ([@B6]; **Figure [2](#F2){ref-type="fig"}**). A significant increase in total vitamin B6 content was observed only in seeds (1.2-fold) and the transgenic lines overexpressing *PDX2* alone apparently had a higher total vitamin B6 content than the transgenic *PDX1* lines. In this study, gene expression was only assessed at the transcript level. However, the protein level also needs to be analyzed to better understand the mechanism behind these observations. On the other hand, the employment of a seed-specific promoter for the expression of both *PDX1.3* and *PDX2*resulted in a threefold increase of total vitamin B6 in transgenic seeds ([@B6]; **Figure [2](#F2){ref-type="fig"}**). In contrast to the work from Herrero and Daub performed with *Cercospora* genes in tobacco, the latter study reported that ectopic expression of the endogenous *PDX* genes in *Arabidopsis* did not affect plant growth and development. However, the choice of *PDX1*gene appears to be particularly important considering a more recent report, which describes an at least fourfold increase in total vitamin B6 content in shoots and seeds, respectively using the 35S CaMV promoter ([@B46]; **Figure [2](#F2){ref-type="fig"}**). In this study, it was shown that plants overexpressing *PDX1.1*at the transcript level also had an increase of the corresponding protein, while *PDX1.3*transcript overexpression did not result in an increase at the protein level, suggesting a tighter regulation of this paralog. Indeed, PDX1.3 is known to be an ubiquitination target for protein degradation by the proteasome ([@B31]). Interestingly, the increase in PDX1.1 protein content was associated with an increased expression of PDX2 and accordingly the vitamin B6 level was increased ([@B46]). However, in contrast to the study of [@B6], overexpression of PDX2 alone did not lead to enhanced levels of vitamin B6 ([@B46]). Overexpression of both *PDX1.1* and *PDX2* in *Arabidopsis* led to even further increases in the vitamin B6 content and therefore, appears to be the best strategy for vitamin B6 enrichment in crop plants. Intriguingly, vitamin hyper-accumulator lines also have larger aerial organs as well as increased seed size through embryo enlargement ([@B46]). Consistent with the previously reported antioxidant properties of vitamin B6, its accumulation in *Arabidopsis*also correlated with improved tolerance to oxidative stress ([@B46]). It is important to mention that the enzymatic activities of PDX1 and PDX2 lead directly to the production of the cofactor form, PLP ([@B47]; [@B57]). However, the enhanced vitamin B6 content in the aforementioned *Arabidopsis* lines was distributed across PN, PM as well as PLP ([@B46]). In this context, it should be noted that in addition to *de novo*biosynthesis, plants also have a so called "salvage pathway" that interconverts the different B6 vitamers. The salvage pathway is common to all living organisms ([@B58]; **Figure [1](#F1){ref-type="fig"}**). In plants, enzymes that are known to be involved include the oxidase PDX3, which transforms PNP or PMP to PLP ([@B50]); a kinase SOS4, which can phosphorylate PL, PN, or PM ([@B52]; [@B53]; [@B28]); a PL reductase ([@B23]) and as yet unknown, perhaps unspecific phosphatases, which can dephosphorylate the phosphorylated vitamers (**Figure [1](#F1){ref-type="fig"}**). Therefore, it is likely that there is cross-talk between *de novo* and salvage pathways of biosynthesis, which should be taken into account in any biofortification strategy. Notwithstanding, the vitamin increase reported by [@B46] would be sufficient to meet the RDA in most staple crops ([@B14]). Furthermore, the reduced bioavailability of glycosylated forms must be taken into account in genetic engineering strategies. Future work should also determine whether the fractions of free, phosphorylated and glycosylated B6 derivatives can be modulated. Such approaches will be instrumental in determining whether particular vitamers are associated with improved agronomic traits.

![**Summary of the genetic approaches used in unraveling the deoxyxylulose 5-phosphate (DXP)-independent pathway for vitamin B6 biosynthesis *de novo*and first proof-of-principle strategies for vitamin B6 biofortification in *Arabidopsis thaliana* and tobacco**. The lower panel provides an overview of the possible new engineering strategies for vitamin B6 biofortification.](fpls-04-00143-g002){#F2}

In order to exploit the benefits of an increased vitamin B6 content, the successful strategy used in *Arabidopsis* remains to be demonstrated in a crop plant. This also requires a good understanding of the regulatory mechanisms that control genes involved in vitamin B6 biosynthesis and metabolism, regardless of whether a biofortification strategy employs heterologous or homologous expression. A better knowledge of the natural diversity of vitamin B6 content and availability in crop species could also be instrumental in selecting the *PDX*orthologs providing the highest increase. Comprehensive studies of provitamin A biosynthesis have revealed intra-species genetic mutations linked to differential accumulation of vitamin A precursors that can be exploited to increase vitamin content in crops ([@B2]; [@B19]; [@B64]; [@B65]). Very limited data is currently available on the inter- and intra-species diversity of vitamin B6 accumulation. A recent survey of various wheat genotypes cultivated under different conditions has shown low variation in vitamin B6 content ([@B51]) but additional genotypes and species should be investigated to assess vitamin B6 accumulation especially in crop plants. Such evaluation should be performed under controlled conditions given the regulation of vitamin B6 biosynthesis and accumulation by various factors ([@B8]; [@B48]).

ALTERNATIVE CROP PLANTS OF POTENTIAL INTEREST
=============================================

In order to select appropriate food crops for vitamin B6 biofortification strategies, two criteria should ideally be taken into account: (1) the crop has to be widely used and of economic importance; (2) vitamin B6 accumulation in the consumed part of the crop plant should not be constrained by physiological or developmental limitations. Genetic engineering using *Arabidopsis* suggests that a comparable increase of vitamin B6 can be reached in shoots and seeds (i.e., four to fivefold; [@B46]). However, it remains to be demonstrated that similar increases can be reached in rice seeds or potato tubers for example. If successful, the combination of the existing nutritional qualities with a higher level of vitamin B6 would provide additional value to already important staple foods. Based on the findings of [@B46] using *Arabidopsis*, an improvement of plant growth and survival could also be expected but remains to be confirmed for other species. In developing countries, much of the population is highly dependent on mainly one staple crop and therefore particularly at risk of inadequate micronutrient intake ([@B49]; [@B54]). Nutritional quality improvement, including fortification of vitamin B6, of these crops could help diminish the occurrence of malnutrition and micronutrient deficiency ([@B63]; [@B54]). The generation of crops combining enhanced levels of bioavailable B6 vitamers and better generic traits such as tolerance to oxidative stresses would represent a valuable tool to improve nutrition and food security.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Hervé Vanderschuren and Wilhelm Gruissem gratefully acknowledge the support of the ETH Zurich. Hervé Vanderschuren, Teresa B. Fitzpatrick, and Wilhelm Gruissem also thank the Swiss National Science Foundation for support of the VITRICA project 31003A_140911. Teresa B. Fitzpatrick gratefully acknowledges the support of the Swiss National Science Foundation grant PP0033_119186 as well as that of the University of Geneva. Teresa B. Fitzpatrick also extends gratitude to the Ernst&Lucie Schmidheiny, Ernest Boninchi and Marc Birkigt Foundations for support.

[^1]: Edited by: *Irene Murgia, Università degli Studi di Milano, Italy*

[^2]: Reviewed by: *Suleyman I. Allakhverdiev, Russian Academy of Sciences, Russia; Daniel Hofius, Swedish University of Agricultural Sciences, Sweden*

[^3]: This article was submitted to Frontiers in Plant Physiology, a specialty of Frontiers in Plant Science.
